Stereotaxis swaps out Hogg as CEO

Stereotaxis, a manufacturer of cardiology instrument control systems, has announced that Michael Kaminski, currently president and chief operations officer (COO) and a member of the board, will assume the title and responsibilities of CEO, effective Jan. 1, 2009.

Kaminski will replace Bevil Hogg, who has served as the CEO since 1997 and will remain a member of the company's board of directors.

The St. Louis-based Stereotaxis said that Kaminski came on board in April 2002 as COO. Prior to that, Kaminski spent nearly 20 years with Batesville, Ind.-based Hill-Rom, a provider of hospital and home healthcare equipment.  

"We have reached a point where my own expertise in creating a new technology and the organization to support it should ideally be succeeded by a leader who brings the experience, expertise and focus necessary for operational execution and who can lead Stereotaxis to greater commercial success,” according to Hogg.

Around the web

GE HealthCare designed the new-look Revolution Vibe CT scanner to help hospitals and health systems embrace CCTA and improve overall efficiency.

Clinicians have been using HeartSee to diagnose and treat coronary artery disease since the technology first debuted back in 2018. These latest updates, set to roll out to existing users, are designed to improve diagnostic performance and user access.

The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.